CURIOSITYSTREAM INC (CURI) Fundamental Analysis & Valuation

NASDAQ:CURI • US23130Q1076

Current stock price

3.354 USD
-0.04 (-1.06%)
Last:

This CURI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. CURI Profitability Analysis

1.1 Basic Checks

  • CURI had negative earnings in the past year.
  • In the past year CURI had a positive cash flow from operations.
  • In the past 5 years CURI always reported negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: CURI reported negative operating cash flow in multiple years.
CURI Yearly Net Income VS EBIT VS OCF VS FCFCURI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 -20M -40M -60M

1.2 Ratios

  • CURI's Return On Assets of -8.49% is on the low side compared to the rest of the industry. CURI is outperformed by 60.76% of its industry peers.
  • Looking at the Return On Equity, with a value of -15.49%, CURI is in line with its industry, outperforming 48.10% of the companies in the same industry.
Industry RankSector Rank
ROA -8.49%
ROE -15.49%
ROIC N/A
ROA(3y)-23.97%
ROA(5y)-24.45%
ROE(3y)-35.06%
ROE(5y)-34.34%
ROIC(3y)N/A
ROIC(5y)N/A
CURI Yearly ROA, ROE, ROICCURI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80 -100

1.3 Margins

  • CURI has a better Gross Margin (56.58%) than 62.03% of its industry peers.
  • In the last couple of years the Gross Margin of CURI has declined.
  • CURI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 56.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y18.54%
GM growth 5Y-1.52%
CURI Yearly Profit, Operating, Gross MarginsCURI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. CURI Health Analysis

2.1 Basic Checks

  • CURI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for CURI has been increased compared to 1 year ago.
  • Compared to 5 years ago, CURI has more shares outstanding
  • CURI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CURI Yearly Shares OutstandingCURI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
CURI Yearly Total Debt VS Total AssetsCURI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

2.2 Solvency

  • CURI has an Altman-Z score of -1.95. This is a bad value and indicates that CURI is not financially healthy and even has some risk of bankruptcy.
  • CURI has a Altman-Z score of -1.95. This is in the lower half of the industry: CURI underperforms 74.68% of its industry peers.
  • There is no outstanding debt for CURI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z -1.95
ROIC/WACCN/A
WACC8.97%
CURI Yearly LT Debt VS Equity VS FCFCURI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

2.3 Liquidity

  • CURI has a Current Ratio of 1.23. This is a normal value and indicates that CURI is financially healthy and should not expect problems in meeting its short term obligations.
  • CURI's Current ratio of 1.23 is in line compared to the rest of the industry. CURI outperforms 58.23% of its industry peers.
  • CURI has a Quick Ratio of 1.23. This is a normal value and indicates that CURI is financially healthy and should not expect problems in meeting its short term obligations.
  • CURI has a Quick ratio of 1.23. This is comparable to the rest of the industry: CURI outperforms 59.49% of its industry peers.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 1.23
CURI Yearly Current Assets VS Current LiabilitesCURI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. CURI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 54.17% over the past year.
  • The Revenue has grown by 40.14% in the past year. This is a very strong growth!
  • CURI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.58% yearly.
EPS 1Y (TTM)54.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-40%
Revenue 1Y (TTM)40.14%
Revenue growth 3Y-2.8%
Revenue growth 5Y12.58%
Sales Q2Q%35.82%

3.2 Future

  • The Earnings Per Share is expected to grow by 76.66% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, CURI will show a small growth in Revenue. The Revenue will grow by 7.31% on average per year.
EPS Next Y132.45%
EPS Next 2Y80.33%
EPS Next 3Y65.14%
EPS Next 5Y76.66%
Revenue Next Year13.26%
Revenue Next 2Y13.08%
Revenue Next 3Y11.57%
Revenue Next 5Y7.31%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CURI Yearly Revenue VS EstimatesCURI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20M 40M 60M 80M 100M
CURI Yearly EPS VS EstimatesCURI Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1

More info and screens

Find the best growth stocksShow best growing peers

4

4. CURI Valuation Analysis

4.1 Price/Earnings Ratio

  • CURI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • With a Price/Forward Earnings ratio of 93.95, CURI can be considered very expensive at the moment.
  • CURI's Price/Forward Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.62, CURI is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 93.95
CURI Price Earnings VS Forward Price EarningsCURI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60 80

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CURI is valued a bit cheaper than 70.89% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CURI indicates a rather cheap valuation: CURI is cheaper than 87.34% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 15.35
EV/EBITDA 22.35
CURI Per share dataCURI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

  • CURI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as CURI's earnings are expected to grow with 65.14% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y80.33%
EPS Next 3Y65.14%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. CURI Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 9.36%, CURI is a good candidate for dividend investing.
  • CURI's Dividend Yield is rather good when compared to the industry average which is at 9.16. CURI pays more dividend than 98.73% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.81, CURI pays a better dividend.
Industry RankSector Rank
Dividend Yield 9.36%

5.2 History

  • CURI has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
CURI Yearly Dividends per shareCURI Yearly Dividends per shareYearly Dividends per share 2024 2025 2026 0.1 0.2 0.3

5.3 Sustainability

  • The earnings of CURI are negative and hence is the payout ratio. CURI will probably not be able to sustain this dividend level.
DP-342.46%
EPS Next 2Y80.33%
EPS Next 3Y65.14%
CURI Yearly Income VS Free CF VS DividendCURI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 2025 0 20M -20M -40M -60M

More info and screens

Find the best dividend stocksShow peers with best dividend

CURI Fundamentals: All Metrics, Ratios and Statistics

CURIOSITYSTREAM INC

NASDAQ:CURI (4/24/2026, 11:48:38 AM)

3.354

-0.04 (-1.06%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)03-11
Earnings (Next)05-12
Inst Owners34.29%
Inst Owner Change-0.08%
Ins Owners8.77%
Ins Owner Change2.62%
Market Cap198.86M
Revenue(TTM)71.66M
Net Income(TTM)-6.43M
Analysts86
Price Target6.5 (93.8%)
Short Float %5.82%
Short Ratio6.01
Dividend
Industry RankSector Rank
Dividend Yield 9.36%
Yearly Dividend0.38
Dividend Growth(5Y)N/A
DP-342.46%
Div Incr Years1
Div Non Decr Years1
Ex-Date03-06
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-121.33%
Min EPS beat(2)-128.76%
Max EPS beat(2)-113.9%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)4.71%
Min Revenue beat(2)-0.07%
Max Revenue beat(2)9.49%
Revenue beat(4)2
Avg Revenue beat(4)5.68%
Min Revenue beat(4)-0.09%
Max Revenue beat(4)13.4%
Revenue beat(8)3
Avg Revenue beat(8)1.59%
Revenue beat(12)6
Avg Revenue beat(12)1.36%
Revenue beat(16)8
Avg Revenue beat(16)-1.4%
PT rev (1m)-1.92%
PT rev (3m)-1.92%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-40%
EPS NY rev (1m)75%
EPS NY rev (3m)75%
Revenue NQ rev (1m)1.21%
Revenue NQ rev (3m)2.89%
Revenue NY rev (1m)2.13%
Revenue NY rev (3m)4.92%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 93.95
P/S 2.78
P/FCF 15.35
P/OCF 15.23
P/B 4.79
P/tB 18.96
EV/EBITDA 22.35
EPS(TTM)-0.11
EYN/A
EPS(NY)0.04
Fwd EY1.06%
FCF(TTM)0.22
FCFY6.51%
OCF(TTM)0.22
OCFY6.57%
SpS1.21
BVpS0.7
TBVpS0.18
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -8.49%
ROE -15.49%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 56.58%
FCFM 18.08%
ROA(3y)-23.97%
ROA(5y)-24.45%
ROE(3y)-35.06%
ROE(5y)-34.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y18.54%
GM growth 5Y-1.52%
F-Score6
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 0.7%
Cap/Sales 0.14%
Interest Coverage N/A
Cash Conversion 177.14%
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 1.23
Altman-Z -1.95
F-Score6
WACC8.97%
ROIC/WACCN/A
Cap/Depr(3y)0.24%
Cap/Depr(5y)0.45%
Cap/Sales(3y)0.05%
Cap/Sales(5y)0.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-40%
EPS Next Y132.45%
EPS Next 2Y80.33%
EPS Next 3Y65.14%
EPS Next 5Y76.66%
Revenue 1Y (TTM)40.14%
Revenue growth 3Y-2.8%
Revenue growth 5Y12.58%
Sales Q2Q%35.82%
Revenue Next Year13.26%
Revenue Next 2Y13.08%
Revenue Next 3Y11.57%
Revenue Next 5Y7.31%
EBIT growth 1Y44.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year333.41%
EBIT Next 3Y77.45%
EBIT Next 5Y39.2%
FCF growth 1Y58.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y60.19%
OCF growth 3YN/A
OCF growth 5YN/A

CURIOSITYSTREAM INC / CURI Fundamental Analysis FAQ

What is the fundamental rating for CURI stock?

ChartMill assigns a fundamental rating of 4 / 10 to CURI.


Can you provide the valuation status for CURIOSITYSTREAM INC?

ChartMill assigns a valuation rating of 4 / 10 to CURIOSITYSTREAM INC (CURI). This can be considered as Fairly Valued.


What is the profitability of CURI stock?

CURIOSITYSTREAM INC (CURI) has a profitability rating of 1 / 10.


What is the financial health of CURIOSITYSTREAM INC (CURI) stock?

The financial health rating of CURIOSITYSTREAM INC (CURI) is 5 / 10.


Is the dividend of CURIOSITYSTREAM INC sustainable?

The dividend rating of CURIOSITYSTREAM INC (CURI) is 4 / 10 and the dividend payout ratio is -342.46%.